
Â
Why NOS3 (eNOS) Matters in Endothelial BiologyÂ
 Nitric oxide (NO) produced by endothelial nitric oxide synthase is a major regulator of vascular homeostasis. Endothelial NO signaling contributes to vascular tone, angiogenesis, endothelial migration, vascular permeability, platelet regulation, and inflammatory responses.
eNOS activity is also influenced by physiological stimuli, including blood-flow-associated shear stress. Proper regulation of eNOS and NO production is essential for maintaining endothelial function, whereas impaired NO bioavailability and increased oxidative stress are important features of endothelial dysfunction. Because NO regulates multiple endothelial functions, impaired eNOS signaling has been implicated in cardiovascular disease, hypertension, metabolic disease, vascular inflammation, and vascular aging.Â
As a result, many endothelial cell-based assays—including angiogenesis, migration, permeability, oxidative stress, and inflammatory signaling—can reflect differences in eNOS-dependent biology [1,2].
Â
Why Genotype Matters in Endothelial Cell Research
Â
Primary endothelial cells from different donors are not biologically identical. Genetic background can contribute to differences in gene expression and cellular responses, while other factors—including culture conditions—can also substantially affect endothelial phenotypes.
Donor genetic background and culture conditions can influence the transcriptomic profiles and functional characteristics of primary endothelial cells [7]. These sources of variability can complicate comparison between experiments and interpretation of treatment-dependent effects.
When donor genotype is unknown, inherited genetic differences may therefore contribute to observed variation between experimental groups. Genotype-defined primary cells provide researchers with an opportunity to control or stratify this biological variable when studying genotype-dependent cellular responses.
Â
The Challenge with Conventional Endothelial Models
Â
Most endothelial studies rely on one of three experimental models:
- Primary endothelial cells from donors of unknown genotype
- Immortalized endothelial cell lines
- CRISPR-edited or iPSC-derived endothelial cells
Each model has advantages and limitations. Primary cells provide physiologically relevant human endothelial biology but may vary between donors. Immortalized cell lines provide experimental convenience and reproducibility but may not fully reproduce the characteristics of primary human endothelium.
CRISPR-edited and iPSC-derived endothelial models are powerful tools for investigating individual genetic variants under controlled conditions. However, naturally occurring primary endothelial cells retain the broader genetic background and biological characteristics of the original human donor.
Genotype-defined primary endothelial cells therefore provide a complementary model for studying naturally occurring human genetic variation while preserving the characteristics of primary human endothelium.
Many laboratories perform donor genotyping before experiments to identify the genetic background of their cell models. Providing genotype information with primary cells can simplify study design and reduce the need for additional donor screening.
Â

Â
Â
Introducing NOS3 Genotype-Defined Human Aortic Endothelial CellsÂ
 
Our Human Aortic Endothelial Cells – NOS3 (eNOS) Pharmacogenetic Genotype Bundle addresses these challenges by providing authenticated primary endothelial cells with verified genotype information.
Available Genotypes
| Cell Type | NOS3 rs1799983 (G>T) / (Glu298Asp) | NOS3 rs2070744 (-786T>C) |
|---|---|---|
| Human Coronary Artery Endothelial Cells (Cat. No. 6020) |
âś…Â GG (Wild Type)
âś…Â GT (Heterozygous)
âś…Â TT (Homozygous Variant)
|
âś…Â TT (Wild Type)
âś…Â CT (Heterozygous)
|
| Human Aortic Endothelial Cells (Cat. No. 6100) |
âś…Â GG (Wild Type)
âś…Â TT (Homozygous Variant)
|
âś…Â TT (Wild Type)
âś…Â CT (Heterozygous)
âś…Â CC (Homozygous Variant)
|
Researchers can directly compare endothelial responses associated with NOS3 genotype while preserving the physiological characteristics of native human endothelium.
Â
NOS3 Genotyped Cells
Explore the Products
The Human Aortic Endothelial Cells (Cat. No. 6100) and Human Coronary Artery Endothelial Cells (Cat. No. 6020) – NOS3 (eNOS) Pharmacogenetic Genotype Bundle are available with genotype-defined donor options.Â
For Human Aortic Endothelial Cells, GG and TT genotypes are available for rs1799983, with TT, CT, and CC genotype information available for rs2070744.
For Human Coronary Artery Endothelial Cells, GG, GT, and TT genotypes are available for rs1799983, with TT and CT genotype information available for rs2070744.
Â
Kindly contact our technical support team to discuss the right genotype configuration for your study. We are here to help.